Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adaptation of hollow-fiber-based cell culture technology for the manufacturing of (1) neo-islets, employed for the treatment of type 1 and type 2 diabetes mellitus, and (2) the generation of exosomes from various cell types, used in the treatment of different organ injuries and diseases

Adaptation of hollow-fiber-based cell culture technology for the manufacturing of (1) neo-islets, employed for the treatment of type 1 and type 2 diabetes mellitus, and (2) the generation of exosomes from various cell types, used in the treatment of different organ injuries and diseases

US Patent 12281330 · Granted Apr 22, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus th2022
Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure2013
Marrow stem cell and pancreatic β cell fusion cell useful for the treatment of d2013
Marrow stem cell and pancreatic beta cell fusion cell useful for the treatment o2012
Compositions and methods related to erythropoietin2011
Erythropoietin for treatment of multi-organ failure2011
Method of use of erythropoietin to treat ischemic acute renal failure2004